Sales decline 0.59% to Rs 1363.00 crore
Net profit of Natco Pharma declined 23.46% to Rs 518.40 crore in the quarter ended September 2025 as against Rs 677.30 crore during the previous quarter ended September 2024. Sales declined 0.59% to Rs 1363.00 crore in the quarter ended September 2025 as against Rs 1371.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales1363.001371.10 -1 OPM %42.4958.66 -PBDT666.10864.00 -23 PBT613.70818.20 -25 NP518.40677.30 -23Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
